Log in
Diseases of the respiratory system

Common cold

The common cold is a self-limited viral infection of the upper respiratory tract, most often caused by rhinovirus, presenting with nasal congestion, rhinorrhea, sore throat, and mild cough. It affects people of all ages but is especially frequent in young children, who average several episodes per year. The single most testable fact: diagnosis is clinical, and antibiotics have no role because the etiology is viral.

Practice questionsHigh-yield facts
ICD-10J00
Typical patientAny age, more frequent in young children, fall/winter
Key findingClear rhinorrhea, nasal congestion, mild sore throat, no high fever
First-line treatmentSupportive care: rest, fluids, analgesics, decongestants
5 min readFor medical studentsUpdated 2026-10-14

Definition and epidemiology

The common cold is an acute, self-limited viral infection of the nasal mucosa and upper airway. It is the most frequent acute illness in humans and a leading cause of outpatient visits and missed school or work days worldwide.

  • Adults average 2-4 colds per year; children average 6-8, reflecting less prior immunity and close contact in daycare/school settings.
  • Incidence peaks in fall and winter in temperate climates, related to indoor crowding and possibly cooler, drier air favoring viral transmission, not cold temperature itself causing illness.
  • Transmission occurs via respiratory droplets, aerosols, and contact with contaminated surfaces followed by self-inoculation of the nasal or conjunctival mucosa.
  • The condition is nearly universal; essentially all people experience colds repeatedly throughout life because of the large number of causative serotypes and strains.
High-yield for exams
  • Rhinovirus is the most common causative agent of the common cold.
  • Discolored nasal discharge is a normal part of viral illness, not a sign of bacterial infection.
  • Diagnosis is clinical; no routine labs or imaging are needed.
  • Antibiotics are never indicated for an uncomplicated common cold.
  • Fever is uncommon in adults but more frequent in young children.
  • Symptoms peak around day 2-3 and typically resolve within 7-10 days; cough may persist up to 3 weeks.
  • Topical decongestants should be used only briefly to avoid rebound congestion.
  • Acute otitis media and bacterial rhinosinusitis are the main secondary complications to watch for.

Etiology and risk factors

Causative organisms

  • Rhinovirus is the most common cause, accounting for 30-50% of colds, with over 100 serotypes limiting lasting cross-immunity.
  • Other viruses: coronaviruses (non-SARS seasonal strains), respiratory syncytial virus (RSV), parainfluenza virus, adenovirus, human metapneumovirus, and influenza (which more often causes a more severe systemic illness).

Risk factors

  • Young age (immature immune experience, daycare/school exposure)
  • Close contact with infected individuals (household, classroom)
  • Fall and winter season
  • Smoking or secondhand smoke exposure (impairs mucociliary clearance)
  • Psychological stress and poor sleep (associated with increased susceptibility in studies)
  • Fatigue and crowded or poorly ventilated environments

Pathophysiology

Viral particles are inhaled or self-inoculated onto nasal or conjunctival epithelium, where rhinovirus binds ICAM-1 receptors on respiratory epithelial cells and begins local replication.

  • Direct viral cytopathic effect is relatively mild; most symptoms result from the host inflammatory response.
  • Infected epithelial cells release inflammatory mediators (bradykinin, kinins, interleukins, prostaglandins) that increase vascular permeability and mucus gland secretion.
  • This produces nasal vasodilation, edema, and hypersecretion, causing congestion and rhinorrhea.
  • Local inflammation and secretions irritate the pharynx (sore throat) and stimulate cough receptors, especially from postnasal drip.
  • Fever is usually absent or low-grade in adults because the infection remains localized to the upper airway mucosa rather than causing systemic viremia.

Clinical features

Onset is typically gradual over 1-2 days following an incubation period of about 1-3 days.

  • Nasal congestion and rhinorrhea (initially clear/watery, often becoming thicker and discolored later in the illness, which does not indicate bacterial superinfection)
  • Sore or scratchy throat, often the earliest symptom
  • Sneezing
  • Mild to moderate cough, usually from postnasal drip
  • Low-grade fever is uncommon in adults but more frequent in young children
  • Mild malaise, headache, and myalgias may occur but are typically less severe than with influenza
  • Symptoms generally peak at 2-3 days and resolve within 7-10 days; cough can linger up to 2-3 weeks

Diagnosis

Diagnosis is clinical, based on history and physical examination; laboratory testing and imaging are not routinely needed.

  • History: gradual onset, predominant nasal/throat symptoms, absence of high fever or severe systemic illness
  • Exam: nasal mucosal edema and clear or mucoid discharge, mildly erythematous pharynx, normal lung auscultation
  • Testing is reserved for atypical presentations or to exclude other conditions (e.g., rapid influenza test, SARS-CoV-2 testing, rapid streptococcal antigen test if streptococcal pharyngitis is suspected)
  • Discolored (yellow/green) nasal discharge alone is a normal part of the viral illness course and does not indicate bacterial sinusitis or warrant antibiotics

Differential diagnosis

ConditionDistinguishing feature
InfluenzaAbrupt onset, high fever, severe myalgias, prominent fatigue
Allergic rhinitisRecurrent/seasonal pattern, itching, sneezing, clear discharge, no fever, nasal pallor
Acute bacterial rhinosinusitisSymptoms persisting >10 days or worsening after initial improvement, facial pain, fever
Streptococcal pharyngitisSevere sore throat, fever, exudates, absence of cough/rhinorrhea, tender anterior cervical nodes
COVID-19Variable; may include anosmia, more systemic symptoms, confirmed by specific testing
PertussisParoxysmal cough with whoop, prolonged course, in under-vaccinated individuals

Management

Treatment is supportive; the illness is self-limited and there is no cure or antiviral agent in routine use for the common cold.

Supportive measures

  • Rest and adequate hydration
  • Analgesics/antipyretics (acetaminophen, ibuprofen) for sore throat, headache, or fever
  • Nasal saline irrigation or sprays to thin secretions
  • Short-term topical or oral decongestants (e.g., oxymetazoline, pseudoephedrine) for congestion relief; topical decongestants should be limited to a few days to avoid rebound congestion (rhinitis medicamentosa)
  • Antihistamines (particularly first-generation) may modestly reduce rhinorrhea/sneezing in some guideline reviews, though evidence is mixed
  • Honey (in children over 1 year) and simple cough measures may help cough symptoms; cough suppressants have limited proven benefit
  • Zinc lozenges and vitamin C have inconsistent evidence; not uniformly recommended across guidelines

Key point

  • Antibiotics are not indicated because the common cold is viral; this is one of the most tested management principles and a target of antibiotic stewardship efforts (WHO, CDC, and major medical societies all emphasize this).
  • Antivirals used for influenza (e.g., oseltamivir) are not used for the common cold.
  • Return precautions: persistent fever beyond a few days, symptoms worsening after initial improvement, or symptoms lasting beyond 10-14 days should prompt reevaluation for secondary bacterial infection or an alternate diagnosis.

Complications and prognosis

Prognosis is excellent; the vast majority of cases resolve fully without sequelae within 1-2 weeks.

  • Acute bacterial rhinosinusitis (secondary bacterial infection of the sinuses)
  • Acute otitis media, particularly in young children, due to eustachian tube dysfunction
  • Exacerbation of asthma or chronic obstructive pulmonary disease in susceptible patients
  • Lower respiratory tract spread (bronchitis, rarely pneumonia), more common in infants, the elderly, or immunocompromised patients
  • Secondary bacterial pharyngitis is uncommon
  • Chronic cough persisting beyond expected duration should prompt evaluation for other causes rather than assuming a prolonged cold

Practice questions

1. A 28-year-old woman presents with 2 days of sore throat, clear nasal discharge, and mild sneezing. She has no fever, and lung exam is normal. She asks for antibiotics because her nasal discharge has become yellow-green. Which of the following is the most appropriate response?

Answer: B. Discolored nasal discharge commonly occurs during the natural course of a viral upper respiratory infection and does not indicate bacterial superinfection. Antibiotics are not warranted unless symptoms persist beyond 10 days, worsen after initial improvement, or there are signs of severe illness. Patient education about the self-limited nature of the illness is the appropriate next step.

2. A 4-year-old boy has had nasal congestion, mild cough, and low-grade fever (38.1°C) for 3 days, attending daycare. He is active, feeding well, and has no respiratory distress. Which management approach is most appropriate?

Answer: C. This presentation is consistent with an uncomplicated viral upper respiratory infection in a well-appearing child. Supportive care is appropriate; antibiotics, antivirals, and imaging are not indicated without signs of bacterial or more severe illness. Low-grade fever is common in children with colds and does not by itself suggest a complication.

3. A 35-year-old man with a 12-day history of nasal congestion and rhinorrhea reports that after initially improving around day 5, his symptoms worsened again with new facial pain, pressure over the maxillary region, and fever of 38.9°C. What is the most likely diagnosis?

Answer: C. A biphasic illness pattern, with initial improvement followed by worsening symptoms, new fever, and facial/maxillary pain after more than 10 days, is classic for acute bacterial rhinosinusitis as a complication of a viral cold. This pattern distinguishes it from a simple prolonged viral cold, which would not show secondary worsening with new focal pain and fever.

Frequently asked questions

What causes the common cold?

The common cold is caused mainly by rhinovirus, along with other viruses such as coronaviruses, RSV, parainfluenza, and adenovirus. These viruses infect the nasal and throat mucosa and trigger an inflammatory response rather than causing severe direct tissue damage. Transmission occurs through respiratory droplets, airborne particles, or contact with contaminated surfaces followed by touching the nose or eyes.

What are the first symptoms of a common cold?

The earliest symptoms are usually a scratchy or sore throat and mild nasal congestion, developing gradually over one to two days. This is followed by clear rhinorrhea, sneezing, and sometimes a mild cough. Fever is uncommon in adults, and symptoms are generally milder than those of influenza.

How is the common cold diagnosed?

The common cold is diagnosed clinically based on symptom history and physical exam, without the need for lab tests or imaging in typical cases. Doctors look for gradual-onset nasal and throat symptoms without high fever or severe systemic illness. Testing is only used to rule out other conditions like influenza, strep throat, or COVID-19 when the presentation is atypical.

Is the common cold curable?

There is no cure for the common cold because it is caused by a virus, but it is self-limited and resolves on its own, usually within 7 to 10 days. Treatment focuses on relieving symptoms with rest, fluids, analgesics, and decongestants rather than eliminating the virus. Antibiotics do not help and are not recommended.

Common cold vs flu — what is the difference?

The common cold has a gradual onset with mild symptoms centered on the nose and throat, while influenza typically starts abruptly with high fever, severe muscle aches, and marked fatigue. Colds rarely cause significant systemic illness, whereas flu can lead to serious complications like pneumonia, especially in high-risk groups. Antiviral treatment exists for influenza but not for the common cold.

Key drugs

AcetaminophenIbuprofenOxymetazolinePseudoephedrineDiphenhydramineDextromethorphan
InfluenzaAllergic rhinitisAcute bacterial rhinosinusitisStreptococcal pharyngitisCOVID-19Acute otitis mediaPertussisBronchiolitis

Sources and further reading

StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: J00

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.